#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenocarcinoma pancreas Pouchitis Scedosporium infection Endometrial cancer recurrent Cryoglobulinaemia Hydrocephalus Malignant central nervous system neoplasm Fusarium infection Neoplasm Marginal zone lymphoma Chondrosarcoma Chronic myeloid leukaemia Glycogen storage disease type I Malignant glioma Factor IX deficiency More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis II – Diagnostics Angiosarcoma metastatic – Diagnostics Hereditary optic atrophy – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) VEXAS syndrome Brain stem glioma – Diagnostics Isodicentric chromosome 15 syndrome – Basic Information Primary immunodeficiency syndrome – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Usher’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VERTEPORFIN Specific Nucleic Acid Sna-Ebv Ly3454738 Pregabalin Protrans TRIGLYCERIDES MEDIUM CHAIN Human Albumin Solution Vincristine Sulfate Olea Europaea Pollen Extract Lutetium (177Lu) Edotreotide Sildenafil POTASSIUM HYDROXIDE Heparin Sodium VHB937 F510/08 Hmb-001 Folic Acid, Anhydrous Human Vaccinia Immunoglobulin ARI0008 Clotrimazole More therapies…

    Learn about Your Condition

    Primary hyperaldosteronism Peritoneal neoplasm Synovitis Immune-mediated enterocolitis Biopsy heart Haemofiltration Pancreatic fistula Pelizaeus-Merzbacher disease Post-traumatic stress disorder Synovial sarcoma recurrent Triple negative breast cancer Diabetic autonomic neuropathy Lymphocyte adoptive therapy Tonsillitis Migraine without aura More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. General University Hospital Of Larissa

General University Hospital Of Larissa

P. O. Box 1425, Larissa, 411 10, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • A Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Ocular myasthenia
    Investigated Drugs:
    • Rozanolixizumab
    France Germany Greece Hungary Italy Poland +1

  • Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Ly3484356
    • Anastrozole
    • Exemestane
    Austria Belgium Czechia Finland France Germany +10

  • Randomized study of ketotifen nasal spray (0.025% and 0.050%) versus sodium cromoglicate nasal spray in patients with rhinitis

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Sodium Cromoglicate
    Greece

  • Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • ADMILPARANT
    Austria Belgium Denmark Finland France Germany +8

  • A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

    Not yet recruiting

    3 1
    Investigated Drugs:
    • ADMILPARANT
    Austria Belgium Czechia Denmark Finland France +9

  • A study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • ADMILPARANT
    Austria Belgium Czechia Denmark Finland France +9

  • Study of Drug Combination with Amodiaquine and Potassium Canrenoate Plus Exenatide or Glibenclamide for Patients with Acute Ischemic Stroke

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Exenatide
    • Glibenclamide
    • Potassium Canrenoate
    Greece

  • A Study Comparing Tacrolimus and Ciclosporin Eye Drops for Children and Adults with Moderate to Severe Vernal Keratoconjunctivitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • Ciclosporin
    • Tacrolimus Monohydrate
    Bulgaria France Greece Italy Spain

  • Study of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Belgium Denmark France Germany Greece Hungary +4

  • Study on Aztreonam, Avibactam, and Metronidazole for Treating Infections in Neonates and Infants Under 9 Months with Gram-Negative Bacterial Infections

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Avibactam Sodium
    • Aztreonam
    • Metronidazole
    Bulgaria Greece Hungary Italy Slovakia Spain
Previous Page
1 … 8 9 10 11 12 … 21
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!